MFDI

MFDI (Molecular Frontiers Drug Innovation) is a biotechnology company focused on the discovery and development of novel therapeutic agents using advanced molecular modeling and computational chemistry. The company leverages its proprietary platform to identify high-affinity ligands for challenging biological targets, including G protein-coupled receptors and ion channels. MFDI's pipeline primarily addresses unmet needs in metabolic diseases, neurological disorders, and oncology. By integrating structural biology with high-throughput screening, the company aims to accelerate the transition from lead identification to clinical candidates. MFDI operates as a private entity, collaborating with academic institutions and pharmaceutical partners to advance its diverse portfolio of small molecule and peptide-based therapies.